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Abstract
Studies have shown that the activity of muscarinic receptors and their affinity
to agonists are sensitive to membrane potential. It was reported that in airway
smooth muscle (ASM) depolarization evoked by high K+ solution increases
contractility through direct effects on M3 muscarinic receptors. In this study,
we assessed the physiological relevance of voltage sensitivity of muscarinic
receptors on ASM contractility. Our findings reveal that depolarization by
high K+ solution induces contraction in intact mouse trachea predominantly
through activation of acetylcholine release from embedded nerves, and to a
lesser extent by direct effects on M3 receptors. We therefore devised a pharmacological approach to depolarize tissue to various extents in an organ bath
preparation, and isolate contraction due exclusively to ASM muscarinic receptors within range of physiological voltages. Our results indicate that unliganded muscarinic receptors do not contribute to contraction regardless of
voltage. Utilizing low K+ solution to hyperpolarize membrane potentials during contractions had no effect on liganded muscarinic receptor-evoked contractions, although it eliminated the contribution of voltage-gated calcium
channels. However, we found that muscarinic signaling was potentiated by at
least 42% at depolarizing voltages (average 12 mV) induced by high K+
solution (20 mmol/L K+). In summary, we conclude that contractions evoked
by direct activation of muscarinic receptors have negligible sensitivity to physiological voltages. However, contraction activated by cholinergic stimulation
can be potentiated by membrane potentials occurring beyond the physiological range of ASM.

Introduction
Airway smooth muscle (ASM) contraction is primarily
mediated by so called “pharmaco-mechanical coupling”
via activation of M2 and M3 muscarinic cholinergic
receptors linked to Gi/o- and Gq-coupled receptors,
respectively (Eglen et al. 1996; Hall 2000; Ehlert 2003;
Sanderson et al. 2008). Stimulation of M3/Gq-coupled
receptors activates phospholipase C which cleaves PIP2
and triggers Ca2+ release from sarcoplasmic reticulum
(SR) via IP3 receptors to initiate contraction (Berridge
1993). M2/Gi/o receptor activation contributes to contraction through inhibition of cAMP signaling (Fryer and

Jacoby 1998). Muscarinic receptor activation also causes a
distinct mode of contraction through activation of ionic
currents that depolarize the plasmallema (Benham et al.
1985; Lee et al. 1993), so called “electro-mechanical coupling”. Depolarization gates opening of voltage-dependent
calcium channels that mediate calcium influx and contribute to contraction (Somlyo and Somlyo 1968). However, the pharmacomechanical and electromechanical
coupling mechanisms have been blurred by studies showing voltage sensitivity of numerous G protein–coupled
receptors (Mahaut-Smith et al. 2008). Among these, the
predominant G protein–coupled receptors in ASM, the
M2 and M3 muscarinic receptors, have been shown to be
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directly sensitive to voltage (Mahaut-Smith et al. 2008;
Rinne et al. 2015). These reports suggest that when
acetylcholine or carbachol is used as an agonist, M2
receptor is activated by depolarization, while M3 receptor
is inhibited by depolarization (Mahaut-Smith et al. 2008;
Rinne et al. 2015).
Previously, it was found that chemical depolarization
with 60 mmol/L K+ extracellular solution increased ASM
contractile force in a manner that is directly dependent
on M3 receptor signaling (Liu et al. 2009). An important
question is whether physiologically relevant voltage
changes also increase muscarinic-evoked contractions of
ASM. While chemical depolarization (e.g., using
60 mmol/L K+ extracellular solution) is a convenient
method to assess the effect of voltage on contraction of
muscle preparations, the actual effect on tissues can be
complex to interpret. ASM generally traverse modest voltage ranges following cholinergic receptor activation, with
reports indicating voltages that are not more positive than
30 mV (Janssen 1998; Semenov et al. 2011). In contrast,
60 mmol/L K+ extracellular solution can theoretically
drive voltage to more depolarized potentials. One can
estimate a Nernst potential of 21 mV, assuming a predominant permeability to potassium and an expected
140 mmol/L intracellular potassium concentration. Actual
measurements suggest depolarizations to ~0 mV with
50 mmol/L potassium solution (Imaizumi and Watanabe
1981). Furthermore, high K+ also depolarizes parasympathetic nerves embedded in ASM preparations, possibly
contributing to contractions via nerve-mediated acetylcholine release (Alberts et al. 1982). This is a particular
issue for ASM, since a superficial buffer barrier to calcium
influx is believed to bias contraction responses to cholinergic receptors more so than voltage-gated calcium channels (Janssen et al. 1999).
The aim of this study is to assess the contribution of
physiologically relevant depolarization-driven activation
of muscarinic receptors on ASM contractility in intact tissues. We hypothesize that contractions in high K+ solutions are confounded by depolarization of ASM beyond
their physiological range, and also confounded by effects
of depolarization via activation of embedded nerves. Both
of these confounds may account for an overestimation of
the physiological role of depolarization on muscarinic
receptor signaling in ASM (Liu et al. 2009). To test the
hypothesis, we took pharmacological approaches to isolate
effects of chemical depolarization (high K+) on muscarinic receptor-dependent contractions. Our findings
reveal that chemical depolarization of intact trachea
preparations predominantly mediate contractions through
acetylcholine release from embedded nerves, and to a lesser extent by depolarization of the smooth muscle cells.
Furthermore, voltage-dependent calcium channel blocker,
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nifedipine, or removal of extracellular calcium abolished
contraction via direct voltage-dependent calcium influx.
By eliminating these aforementioned signaling pathways,
we find that depolarization have effects on muscarinicevoked contractions but outside the physiological range
of ASM voltages.

Materials and Methods
Tissue preparations and contraction
recordings
The methods were similar to those described previously
(Semenov et al. 2011). Animals used in these studies were
the background C57BL/6J mice strain from Jackson Labs.
All animal procedures were reviewed and approved by the
University of Texas Health Science Center at San Antonio
Institutional Animal Care and Use Committee. For tracheal contraction studies, animals were first deeply anesthetized with isoflurane in an induction chamber and
then sacrificed by cervical dislocation. Trachea were
quickly removed and dissected clean of surrounding tissues in ice-cold normal physiological saline solution
(PSS). The tracheal tube was cut below the pharynx and
above the primary bronchus bifurcation. Two metal wires,
attached to a force transducer and micrometer (Radnoti,
LLC), were threaded into the lumen of the trachea. The
trachea was placed into an organ bath oxygenated by O2–
CO2 mixture (95% O2 and 5% CO2), at 37°C. This
preparation was not denuded of epithelial cells.
Two platinum electrodes placed on the sides of the
preparation were used to deliver electrical field stimulation (EFS). The electrodes were positioned 4 mm apart
and this distance was maintained constant throughout the
study. All wires and soldered connections were sealed
with Sylgard (Sylgard 184 Silicone Elastomer, Dow Corning Corp., Midland MI) to insulate from the bathing
solution and to prevent leaching of deleterious metals
into the tissue bath. Dependencies of contraction force on
stimulation frequency and voltage were obtained and analyzed. Stimulation at 30 Hz by 0.5 msec pulses (44 V)
was found to be an optimal for our experimental setup to
achieve reproducible (no tissue damage) near-maximal
contractile responses.
Resting tension of ASM preparation was continuously
readjusted in the water bath to 1 g for 1 h. Then, the
preparation was challenged with 60 mmol/L K+ PSS twice
or more until reproducible contraction responses were
achieved. Responses to the subsequent experimental challenges with drugs were normalized to the maximal contraction response in the 60 mmol/L K+ PSS solution. For
experiments that involved two or more cholinergic challenges, we found that the responses to subsequent
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challenges did not show significant fatigue (P = 0.19,
n = 9, students paired t test). On average, the next challenge produced 0.95  1% reduction in response from
that of the previous challenge. In case of six challenges
separated by 10 min’ intervals, sixth challenge produced
2  1% reduction in response in comparison with the
first. Normal PSS used was (mmol/L): 119 NaCl, 4.7 KCl,
2.0 CaCl2, 1.0 KH2PO4, 1.17 MgSO4, 18 NaHCO3, 0.026
EDTA, 11 glucose, and 12.5 sucrose. The pH of the solution was adjusted to 7.3 by 95% O2–5% CO2 mixture.
Normal PSS had a total 5.7 mmol/L K+ derived from
4.7 mmol/L KCl plus 1.0 mmol/L KH2PO4. “Low” K+
PSS solution was used to measure contractions in relatively hyperpolarized conditions. Low K+ PSS consisted of
1.0 mmol/L potassium derived from the KH2PO4 with no
added KCl. To maintain proper osmolality both
20 mmol/L and 60 mmol/L potassium PSS contained
reduced sodium of 103.7 and 63.7 mmol/L, respectively.
In 0 Ca2+ solutions, CaCl2 was replaced with 100 lmol/L
EGTA to remove residual Ca2+ ions.
Botulinum neurotoxin A (BTX) treatment protocol was
adopted from Moffatt et al. (2004) with the few modifications. Briefly, BTX stock solution was added to tracheas
submerged in DMEM to achieve final concentration of
BTX 50 nmol/L. Tracheas were incubated with BTX for 3 h
in a tissue culture incubator at 37°C. Tracheas for control
experiment were incubated for the same period at the same
conditions with the equal volume of vehicle instead. After
incubation, tracheas were mounted in the organ bathes as
described above and rinsed with normal PSS. Resting
tension was readjusted for 1 g continuously during 30 min.
Then, preparations were challenged with 60 mmol/L potassium PSS twice. MacLab 8 A/D data-gathering system
(AD Instruments, Inc., Colorado Springs, CO) installed on
Macintosh computer was used to visualize the signals during acquisition and later during data analysis.

Tracheal smooth muscle cell isolation and
sharp electrode recordings
To find detailed procedures for tracheal smooth muscle
cells isolation and sharp electrode recordings, please refer
to Semenov et al. (2011). Here, only a brief description is
provided. The dorsal muscle layer of trachea was minced
into the small pieces in Ca2+-free Krebs solution at the
presence of 2.5 U/mL of papain (MP Biomedicals, Solon,
OH, USA), 1 mg/mL of BSA fraction V. Then, muscle
pieces were shaken at 37°C (250 moves/min) on a rocking platform in the same solution for 20 min, rinsed in
Ca2+-free Krebs solution, mixed with 12.5 U/mL of type
VII collagenase (Sigma-Aldrich Corp.), and placed back
on the rocking platform for 10 min. Digested pieces of
tissue were washed in Ca2+-free Krebs-BSA solution and
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triturated with a fire polished Pasteur pipette to dissociate
single tracheal myocytes. Isolated cells were stored on ice
in Ca2+-free Krebs-BSA solution to be used within 6 h
time. Drop (50 lL) of the suspension of isolated cells was
placed in an open 1.0 mL perfusion chamber mounted
on the stage of an inverted microscope. Cells were
allowed to adhere to the glass bottom of the chamber and
then were continuously perfused with the PSS (0.5–1 mL/
min) containing 5.7, 1.0, or 20 mmol/L of K+ ions. pH of
the solution was maintained at 7.35 by oxygenation with
95% O2–5% CO2 mixture and temperature was held at
37°C using an automatic temperature controller (TC324B, Warner Instruments, LLC, Hamden, CT, USA).
Membrane potentials (Vm) of the single cells were measured using the sharp electrode technique with an EPC-9
amplifier (Heka Electronics). Sharp pipettes (20–60 MΩ)
were pulled from borosilicate capillary glass (1B150F-4,
WPI) using a Sutter P-87 pipette puller. Pipettes were filled
with the 2 mol/L KCl solution. One percentage of Agarose
Type IX-A was added to prevent leak of the pipette solution into the cell. Impalement of cell by a pipette was recognized as a sudden drop of voltage. Resting membrane
potentials were recorded for 1 min to ensure a stability of
the baseline. “Igor” software (Igor, WaveMetrics Inc.) was
used for statistical analyses. Significance was determined
with Student’s t test for paired or unpaired data as appropriate. The effects were deemed significant when a
P < 0.05 was obtained. The results are presented as the
means  standard error of the mean where applicable.

Results
Trachea contraction evoked by chemical
depolarization consists of two major parts:
atropine-sensitive and nifedipine-sensitive
components
To understand the role of voltage on muscarinic signaling, we wished to identify an experimental approach to
affect voltage in ASM and measure contractions due
solely to muscarinic receptor signaling. Figure 1A demonstrates a tracheal ring contraction using a depolarizing
high K+ (60 mmol/L) solution, and examines the contribution of muscarinic receptors (atropine-sensitive contractions) and other pathways (atropine-insensitive
contractions). High K+ in this preparation yielded
approximately 60% of the contraction from a half-maximal concentration of cholinergic agonist carbachol
(0.5 lmol/L, Fig. 1A, summarized in 1B). Atropine, a
muscarinic acetylcholine receptor antagonist, reduced the
contractile response significantly and revealed an atropine-insensitive component of high K+ contraction
(Fig. 1A, right). The atropine-insensitive component has
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a reduced amplitude and prominent two-phase appearance (Fig. 1, A): (1) distinct transient peak (46  5% of
maximal contraction response in the 60 mmol/L KCl at
control conditions) and (2) smaller sustained plateau
(32  2%, n = 6). Zero external calcium eliminated the
atropine-insensitive component of contraction, which was
unsurprising given that this likely represents contraction
mediated by Ca2+ influx via voltage-gated calcium channels. However, we were surprised to find that the Atropine-sensitive component of contraction was also
eliminated by 0 external calcium (Fig. 1A, left). This is
paradoxical given that M3 muscarinic receptors primarily
mediate contraction through calcium-store release mechanisms, and a transient contraction is expected. These
results indicate that high K+ contraction is largely dependent on calcium influx, of which a majority is atropine
sensitive, and a minority is independent of muscarinic
receptors.

The atropine-sensitive component of high
K+ contraction depends on acetylcholine
release from the nerve terminals
As was shown above, the majority of the contractile
response initiated by high K+ depends on two events: (1)
Ca2+ influx and (2) muscarinic receptor activation. A

hypothesis to explain these would be that high K+ depolarizes and activates cholinergic neurotransmission, which
would be dependent on calcium influx into nerve endings
and release of acetycholine onto apposing muscle. We
tested this possibility by using botulinum toxin A (BTX)
to block acetylcholine release from nerve terminals. BTX
acts as a zinc-dependent protease that effectively prevents
exocytosis of acetylcholine presumably due to cleavage of
membrane protein SNAP-25 (Blasi et al. 1993). It was
reported for tracheal rings that botulinum neurotoxin A
inhibits contractions initiated by electrical pulses but has
only a minor effect on the contractions initiated by muscarinic agonists (Moffatt et al. 2004). Hence, treatment
with BTX leaves muscarinic receptors in tracheal preparations free of endogenous stimulation by nerve release of
acetylcholine, but fully susceptible for the stimulation by
externally applied agonists or depolarization.
We corroborated previous studies (Moffatt et al. 2004)
by testing the effects of BTX on the contractions initiated
by electrical field stimulation and cholinergic agonist
(Fig. 2). Because BTX requires a sustained incubation
time (3 h) to fully enter nerve endings, we included a notreatment time control (Fig. 2A, bottom). We found that
contractions initiated by electrical field stimulation
(Fig. 2A, dashed boxes, expanded in inset, 60  6% of
contraction initiated by high K+), presumably acting

Figure 1. Trachea contraction evoked by chemical depolarization consists of a larger atropine-sensitive and smaller, atropine-insensitive
component. (A) Treatments are indicated above the representative traces of ASM contraction: high K+ (60 mmol/L KCl and 2 mmol/L CaCl2),
high K+/0 Ca2+ solution (60 mmol/L KCl, 0 mmol/L CaCl2, and 100 lmol/L EGTA), and CCh (0.5 lmol/L carbachol) in control and after
antagonism of muscarinic receptors with Atropine (1 lmol/L). All traces are normalized to contractions induced in high K+ solution. Hashed
lines (//) indicate a 20 min wash with normal physiological saline solution. (B) Summarized data for A. Amplitude was estimated after
contractions reached at the plateau phase. Results are expressed as the means  standard error of the mean. For any bar n = 6.
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through cholinergic nerves, can be completely blocked
after incubation of the tracheal preparations for 3 h with
50 nmol/L of BTX (1  0.4% after BTX, n = 6). Nontreated trachea showed a reproducible response to a second electric field stimulation (2A and inset, bottom).
These results indicate that electrical stimulation initiates
contraction of ASM mainly due to acetylcholine release
from nerve terminals. By contrast, BTX had only a small
effect (148  3% of high K+ contraction before vs.
111  6% after treatment, n = 3) on contractions stimulated by exogenous application of 0.5 lmol/L of cholinergic agonist carbachol (CCh). Control tracheas also
showed some decrease in contractile force (142  10%
vs. 127  15%, n = 6) after incubation for 3 h with an
equivalent amount of vehicle (Fig. 2A, summarized in
2B).
We utilized BTX to exclude acetylcholine release from
nerve endings and investigated high K+ depolarizationmediated contractions. Tracheal preparations subjected to
BTX (50 nmol/L, top Fig. 3A) and vehicle (bottom,
Fig. 3A) were treated simultaneously. Contractions

Voltage Effects on Muscarinic-Evoked Contractions

initiated by high K+ were measured before and after 3 h
of incubation with BTX (Fig. 3A top) or vehicle (Fig. 3A
bottom). Incubation with BTX significantly reduced the
amplitude of contractions initiated by high K+ (Fig. 3A,
summarized in 3). In the presence of BTX, high K+ contractile responses were dramatically reduced relative to
pre-BTX treatment, or the vehicle control (Fig. 3A, bottom). The BTX-insensitive component had a prominent
two-phase appearance with the transient peak (53  7%
of high K+ contraction, n = 6) and stable plateau
(20  2% of high K+ contraction). This remaining BTXinsensitive component (Fig. 3A, top) was accounted for
by L-type voltage-gated calcium channels as it was insensitive to Atropine (1 lmol/L), and eliminated by L-type
blocker Nifedipine (10 lmol/L). In conclusion, high K+
contraction is mediated by two mechanisms. The majority
of the sustained contraction is mediated by depolarization
and release of acetylcholine from nerve endings resulting
in a pharmacomechanical coupling. The remaining contraction is electromechanical coupling due to voltagedependent calcium channel activation, and calcium influx

Figure 2. Botulinum toxin A (BTX) blocks ASM contraction activated by electric field stimulation but not by cholinergic agonist. (A)
Representative traces of ASM contraction stimulated by CCh (0.5 lmol/L) and electrical pulses (0.5 msec pulses, 30 Hz, 110 V/cm) before and
after treatment with BTX (50 nmol/L) (red traces) in comparison to sham treatment (blue traces); (inset) magnified traces of ASM contraction
stimulated by electrical pulses before and (b) after treatment with BTX. (B) Summarized data for A. Amplitude was estimated after contractions
reached a plateau phase. Results are expressed as the means  standard error of the mean. (***)P < 0.001, NS is nonsignificant (>0.05) For
any bar n = 6.
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into ASM. We can also conclude that unliganded muscarinic receptors do not contribute to contraction since
the remaining BTX-insensitive contractile response is
accounted for by Nifedipine-sensitive, voltage-dependent
calcium channels. Based on these data, we find that contractions mediated through smooth muscle muscarinic
receptors can be observed in high K+ solution by blocking
neurotransmission with either BTX (Figs. 2 and 3), or 0
Ca2+ extracellular solution (Fig. 1). The remaining contractions mediated via postsynaptic voltage-dependent calcium channels can be blocked with Nifedipine (Fig. 3).
Before proceeding with study of voltage effects on muscarinic receptor signaling, we also investigated the various
K+ solutions’ effect on ASM membrane potentials. We
found that membrane potential in low potassium
(1 mmol/L) PSS was hyperpolarized (Fig. 4C and D).
Low K+ solution reduces contractility in response to
cholinergic activation (Fig. 4 A and B), which likely
occurs through hyperpolarization and reduced voltagegated Ca2+ channels activation since channel blocker
Nifedipine (10 lmol/L) blocks a very similar component
of contractile force as low K+ solution (Fig. 4A,

summarized in 4B). Thus, to study voltage sensitivity of
muscarinic receptors, we concluded that solutions that
allow voltage-dependent Ca2+ influx should be avoided.
As discussed above, 0 external calcium also avoids neurotransmitter release. Our protocol therefore used 0 Ca2+
PSS to study voltage sensitivity of muscarinic receptors
upon cholinergic stimulation (CCh, 0.5 lmol/L). To buffer any residual external Ca2+ ions, 100 lmol/L of EGTA
was added to the solution. Before application of CCh,
organ baths (volume of 15 mL) were perfused for
1.5 min (67 mL/min) with 0 Ca2+ PSS to washout Ca2+
ions. To restore the Ca2+ content of SR after cholinergic
stimulation in 0 Ca2+ solution, trachea preparations were
perfused with normal PSS for 20 min between each CCh
administration. Remarkably, we found that Nifedipine
application also had an effect on the contractile response
stimulated by CCh (0.5 lmol/L) in 0 Ca2+ solution
(Fig. 4E). In the presence of Nifedipine, contractile
responses were reduced almost completely to a transient
peak and a very shallow but measurable plateau. These
responses had quite different kinetics in comparison to
responses in 0 Ca2+ solutions that did not contain

Figure 3. The majority of the steady-state high K+ contraction is due to nerve-evoked (BTX-sensitive) activity. (A) Representative traces of ASM
contraction in high K+ PSS before and after treatment with BTX (50 nmol/L) (red traces) in comparison to sham treatment (blue traces).
Atropine (1 lmol/L) has no additional effect after BTX treatment as opposed to control. In the presence of Atropine, Nifedipine (10 lmol/L)
blocks all remaining contractile activity in ASM regardless of pretreatment with BTX. (B) Summarized data for A. Amplitude was estimated after
contractions reached a plateau phase. Results are expressed as the means  standard error of the mean. (*)P < 0.05. For any bar n = 6.
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Nifedipine (Fig. 4E, plateau @ 5 min 29.3  2.5 control
vs. 3.5  0.8 with Nifedipine). Nifedipine (10 lmol/L)
was therefore added to all solutions to prevent possible
effects of direct coupling of L-type Ca2+ channels to RyR1
(Du et al. 2006) or Gq proteins (del Valle-Rodriguez et al.
2003). Solutions containing various concentrations of K+
ions (1, 5.7, 20, and 60 mmol/L) were used to control
membrane potential of ASM plasma membranes.

Physiological voltage changes do not affect
muscarinic evoked contractions
Figure 5A shows the contractile response that is due to
isolated effects of muscarinic receptor activation, and at
various voltages controlled by external potassium concentrations. The cholinergic-evoked contractile response in

Voltage Effects on Muscarinic-Evoked Contractions

normal K+ (Fig. 5A, 5.7 mmol/L K+) in the absence of
calcium influx is small compared to contractions with calcium influx (Fig. 5A, CCh, 5.7 mmol/L K+). In contrast
to calcium influx pathways that were highly sensitive to
1 mmol/L hyperpolarizing K+ solution (Fig. 4A), cholinergic-evoked contractions in absence of calcium influx
were unaffected by membrane hyperpolarization (Fig. 5A,
1 mmol/L K+). No differences in amplitudes of contractile responses were observed in 1 mmol/L K+ and
5.7 mmol/L K+ PSS (Fig. 5A, summarized in 5B), suggesting that cholinergic signaling is insensitive to physiological voltage changes.
To depolarize the membrane above the physiological
range for smooth muscle, we evoked contractions in the
presence of a 20 mmol/L K+ PSS solution. Voltage measurements in this solution indicated an average voltage of

Figure 4. Low K+ PSS (1 mmol/L) hyperpolarize and high K+ PSS (20 mmol/L) depolarize membrane potential of ASM cells. (A) Representative
traces of ASM contraction stimulated by CCh (0.5 lmol/L) in the control conditions and low K+ PSS. Nifedipine (10 lmol/L) does not have
statistically significant effect on the CCh-evoked contraction compared to tracheas incubated in low K+ PSS. (B) Summarized data for A.
Amplitude was estimated after contractions reached a plateau phase. Results are expressed as the means  standard error of the mean. For
any bar n = 6. (C) Representative traces of resting potentials in ASM perfused with 1, 5.7, and 20 mmol/L K+ PSS. (D) Summarized data for C.
Results are expressed as the means  standard error of the mean. (E) Representative traces of ASM contractile response to cholinergic agonist
in the 0 Ca2+/100 lmol/L EGTA PSS with (red trace) and without (blue trace) Nifedipine (10 lmol/L).
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Figure 5. Voltage has a small influence on muscarinic receptor-evoked contractions. (A) Representative traces of ASM contraction stimulated
by CCh (0.5 lmol/L) in extracellular solutions with different concentrations of K+ ions. Extracellular solutions contained 0 Ca2+ PSS in the
presence of EGTA (100 lmol/L) and Nifedipine (10 lmol/L). (B) Summarized data for A. Amplitude was estimated at the peak of the contractile
responses. Results are expressed as the means  standard error of the mean. (**)P < 0.01. For any bar n = 5.

12  3 mV (n = 12, Fig. 4C and summarized in D),
which is well above the average 44  2 mV potential
(n = 40, Fig. 4C and summarized in D) in normal PSS
solution. We observed a small, but significant potentiation of transient peak by the depolarization with
20 mmol/L K+ (from 19.7  2% to 28  1.2%, P ≤ 0.01,
n = 5, Fig. 5A and summarized in 5B). Cholinergic stimulation in the presence of 60 mmol/L K+ initiated transient contractile response with the tendency to be larger
(35  6, n = 5) than response in 20 mmol/L K+
(Fig. 5A), although this was not statistically significant
increase. Application of Atropine abolished all contractile
activity in the 0 Ca2+ PSS (Fig. 5A) confirming the role
of muscarinic receptors. In summary, changes in voltages
from normal PSS to hyperpolarizing solutions appear to
have little effect on muscarinic receptor-evoked contractions. However, depolarizing voltage increases, as provided by 20 or 60 mmol/L K+ solutions, did increase
muscarinic-evoked contractions.

Discussion
The focus of this study was to evaluate the physiological
effects of voltage on muscarinic receptor-evoked ASM
contractility. Our data suggest that (1) effect of voltage
sensitivity of muscarinic receptors on ASM contraction
becomes significant only at plasma membrane potentials
that are beyond physiological ranges and (2)
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depolarization of plasma membrane alone cannot activate
contractions through muscarinic receptors; ligand binding
is also required.

Major signaling cascades evoked by high
K+ depolarization
High K+ contractions are often used in smooth muscle
contractility studies to normalize contractile responses to
the mass or health of a tissue preparation (Herlihy et al.
1032; Semenov et al. 2012). It was generally assumed that
high K+ solution mediates contraction through smooth
muscle depolarization and activation of voltage-gated calcium channels. In isolating conditions to evaluate voltage
effects on muscarinic receptors, we can infer that a larger
component of the contraction was due to high K+ depolarization of parasympathetic nerves that release acetylcholine onto apposing airway smooth muscle cells. This
causes activation of muscarinic receptor signaling and calcium release, and also voltage-dependent, calcium influx
pathways to cause muscle contraction. Thus, contraction
of ASM in high K+ solution has two major pharmacologically sensitive parts: first – a large atropine-sensitive component due to indirect effects of depolarization on
cholinergic nerves; and second – a smaller nifedipine-sensitive component due to direct effects of depolarization
on voltage-dependent ASM channels. The existence of the
two pathways explains why neither nifedipine nor
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atropine could abolish contraction, and only application
of both could completely prevent the contractile response
to high K+.

Zero Ca2+ external solution and Nifedipine
isolates contractile effects of muscarinic
receptors
An important aspect of these studies was to identify conditions for isometric contractions that are due only to
smooth muscle muscarinic receptors. Ultimately, we
found that 0 calcium external solution suited this purpose. The 0 external calcium solution prevents high K+
depolarization-induced acetylcholine release from nerve
endings. As well, 0 calcium external solution with added
Nifedipine prevents voltage-dependent calcium influx in
the smooth muscle. Depolarization has also been shown
to activate a Rho and Rho-activated kinase-dependent
contraction, which is blocked by Nifedipine (Liu et al.
2005). It is likely that some calcium-dependent signaling
cascades, downstream of muscarinic receptor activation,
are also prevented using 0 external calcium external solution. Conceptually, this would include store-operated calcium influx that follows muscarinic-evoked calcium
release (Ay et al. 2004), and second messenger–activated
calcium permeable channels such as TrpM and TrpC
channels (Gosling et al. 2005). The remaining calcium
signaling that is downstream of Gq-coupled M3 receptor
activation likely underlies the contraction due to high K+
depolarization and muscarinic receptor activation that is
the focus of this study. This likely includes IP3 receptormediated calcium release, and calcium-induced (ryanodine receptor) calcium release. As well, Rho-dependent
contractions can also be mediated by calcium release
mechanisms (Liu et al. 2005).
Although this study carefully investigated the influence
of cholinergic nerves which play a predominant role, it is
worth noting that other cell types, such as airway epithelial cells (Vanhoutte 2013) and sympathetic nerves (van
Nieuwstadt et al. 1994), can release factors in response to
chemical depolarization that influence contractility of tracheal smooth muscle cells. These are factors released from
tissue such as prostaglandins and nitric oxide (Ruan et al.
2011; Kloesch et al. 2016; Blatter 2017), and autonomic
neurotransmitters such as norepinephrine (Garssen et al.
1990) that affect ASM. Under conditions where we
attempted to isolate depolarization-mediated effects, then
0 calcium external solution would be expected to prevent
depolarization-induced secretion of these factors or sympathetic neurotransmitter release (Atlas 2001). Indeed, the
ability of the 0 calcium, nifedipine external solution to
isolate effects due to muscarinic receptors was corroborated by the observation that muscarinic antagonist

Voltage Effects on Muscarinic-Evoked Contractions

atropine completely reversed the contractions (Fig. 5).
However, future studies are needed to conclusively
exclude the contributions of other tissues on chemical
depolarization-induced contractions.

Depolarization of unliganded muscarinic
receptors do not affect ASM contractility
Our experiments that used high K+ to depolarize muscle
and BTX to prevent acetycholine release from nerve endings (Fig. 3) allowed us to determine if voltage-activated,
unliganded muscarinic receptors affect contraction. Under
these circumstances, we saw no atropine-sensitive component of contraction, which suggest that unliganded muscarinic receptors have no role in contractility, despite
depolarization. Similar to our findings, others have shown
that ligand binding is required for voltage-dependent
effects on muscarinic receptors (Rinne et al. 2015). As
expected, depolarization-induced contractions, in the
absence of acetylcholine release (BTX), were solely due to
L-type voltage-gated calcium channels, as these contractions were fully blocked by Nifedipine.

Physiological voltage increases do not
affect muscarinic-evoked contractions
A key finding was that the isolated muscarinic-evoked
contractions (Fig. 5A) were insensitive to hyperpolarizing
solution, suggesting that muscarinic receptors are not
affected by physiological voltages. The explanation may
be that depolarization of ASM plasma membrane upon
cholinergic stimulation is considered to be relatively moderate (Janssen 2002). Our own studies indicate that application of half-maximal concentrations of CCh results only
in 5–7 mV depolarization of ASM plasma membrane
from average resting voltages of 44 mV (Semenov et al.
2011; Evseev et al. 2013). Such depolarization falls within
a voltage window that recruits nifedipine-sensitive calcium channels to contractions (Fleischmann et al. 1994),
and this effect was reversed by hyperpolarizing solution
(Fig. 4). Nevertheless, depolarization with 20 mmol/L K+
PSS, that depolarizes plasma membrane to nonphysiological voltages, from -44 mV to 12 mV (Fig. 5), did yield
measurable effects on muscarinic receptor-mediated contraction. In past studies of voltage effects on ASM muscarinic receptor-evoked contractions, potassium solutions
were used that cause depolarizing voltages changes (Liu
et al. 2009), consistent with the effect observed with 20
and 60 mmol/L K+ solutions (Fig. 5). Previous studies
have shown that Ca2+ release triggered by cholinergic
stimulation in coronary myocytes can be potentiated by
significant (to 0 mV) depolarization (Ganitkevich and
Isenberg 1993). The mechanism is ascribed to a
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depolarization-induced conformational change in the
GPCR domain that couples to the G protein. As a result,
the likelihood of the receptor’s coupling to the G protein
increases, and so is the affinity of the receptor toward the
agonist (Ben-Chaim et al. 2006).

Conclusion
Our goal was to isolate muscarinic receptor signaling in
an intact ASM tissue, and investigate the physiological
consequences of voltage sensitivity on contractile
responses. Our results suggest that while large chemical
depolarizations do increase contractility, the physiological
range of membrane potentials of ASM has minimal if any
effect on the muscarinic-evoked contractile response of
ASM. However, muscarinic receptors do occur in phasic
smooth muscle tissues such as bladder and gut smooth
muscle that undergo larger depolarization (Young 2007;
van Helden et al. 2010). Studies in those tissue may reveal
a larger role for voltage activation of muscarinic
receptors.
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